These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 22328338)
21. Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis. Shin EA; Sohn EJ; Won G; Choi JU; Jeong M; Kim B; Kim MJ; Kim SH Oncotarget; 2014 Jul; 5(14):5624-36. PubMed ID: 25015549 [TBL] [Abstract][Full Text] [Related]
22. Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein. Yoshida T; Shiraishi T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T Cancer Res; 2005 Jul; 65(13):5662-7. PubMed ID: 15994939 [TBL] [Abstract][Full Text] [Related]
23. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A. Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475 [TBL] [Abstract][Full Text] [Related]
25. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731 [TBL] [Abstract][Full Text] [Related]
26. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation. Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955 [TBL] [Abstract][Full Text] [Related]
27. FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells. Woo SM; Seo BR; Min KJ; Kwon TK Oncotarget; 2015 May; 6(13):11614-26. PubMed ID: 25843953 [TBL] [Abstract][Full Text] [Related]
28. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Kim IY; Kang YJ; Yoon MJ; Kim EH; Kim SU; Kwon TK; Kim IA; Choi KS Neuro Oncol; 2011 Mar; 13(3):267-79. PubMed ID: 21292685 [TBL] [Abstract][Full Text] [Related]
29. Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis. Lee DH; Kim DW; Lee HC; Lee JH; Lee TH Biochem Biophys Res Commun; 2014 Apr; 446(4):815-21. PubMed ID: 24491546 [TBL] [Abstract][Full Text] [Related]
30. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Zhang X; Li W; Olumi AF Clin Cancer Res; 2007 Dec; 13(23):7181-90. PubMed ID: 18056199 [TBL] [Abstract][Full Text] [Related]
31. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways. Do MT; Na M; Kim HG; Khanal T; Choi JH; Jin SW; Oh SH; Hwang IH; Chung YC; Kim HS; Jeong TC; Jeong HG Food Chem Toxicol; 2014 Sep; 71():51-9. PubMed ID: 24930757 [TBL] [Abstract][Full Text] [Related]
32. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2. Yang ES; Woo SM; Choi KS; Kwon TK Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768 [TBL] [Abstract][Full Text] [Related]
33. Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Shin SW; Park JW Biochim Biophys Acta; 2013 Mar; 1833(3):723-30. PubMed ID: 23247106 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086 [TBL] [Abstract][Full Text] [Related]
35. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278 [TBL] [Abstract][Full Text] [Related]
36. An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins. Subramaniam A; Loo SY; Rajendran P; Manu KA; Perumal E; Li F; Shanmugam MK; Siveen KS; Park JI; Ahn KS; Hui KM; Kumar AP; Sethi G Apoptosis; 2013 Oct; 18(10):1175-87. PubMed ID: 23700228 [TBL] [Abstract][Full Text] [Related]
37. Oligomycin A enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression. He L; Jang JH; Choi HG; Lee SM; Nan MH; Jeong SJ; Dong Z; Kwon YT; Lee KS; Lee KW; Chung JK; Ahn JS; Kim BY Mol Carcinog; 2013 Feb; 52(2):85-93. PubMed ID: 23335397 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279 [TBL] [Abstract][Full Text] [Related]
39. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5. Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888 [TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Shankar S; Siddiqui I; Srivastava RK Mol Cell Biochem; 2007 Oct; 304(1-2):273-85. PubMed ID: 17636462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]